HUAWEI
During the Huawei Day 0 Forum at MWC Barcelona 2022, Huawei released a series of new IT products and solutions as part of a new "intelligent IT foundation" for operators. David Wang, Executive Director of the Board and Chairman of the ICT Infrastructure Managing Board at Huawei, explained in his keynote speech titled "+IT, New Growth" that this reliable and efficient IT foundation will help operators go intelligent, increase revenue, reduce costs, boost efficiency, and ultimately achieve new growth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220228005736/en/
With the rapid development of emerging technologies like 5G, IoT, cloud computing, and intelligence, operators have put their own digital transformations at the top of their agendas so that they can later help other B2B industries to go digital. This kind of transformation however requires IT infrastructure upgrades, multi-cloud collaboration, and quick market wins to generate more momentum.
Wang explained that Huawei's intelligent IT foundation is specifically designed to help operators meet these new requirements. This foundation includes a fully-collaborative distributed cloud and an all-scenario data pool.
At the same event, Huawei also launched the industry's first ever distributed, cloud-native solution. This fully-collaborative cloud helps operators to achieve ICT orchestration, cloud-network synergy, and cloud-edge synergy. The architecture supports both data and media platforms as a service for operators and application platform as a service (aPaaS) for industry customers. This delivers guaranteed experiences for app users unlimited by geography, multi-cloud collaboration, and data traffic. The company currently says that one day, it hopes to offer everything as a service.
Huawei also announced a new series of data infrastructure products as part of its OneStorage strategy to support continual storage evolution. As data types continue to diversify, applications have become more affordable and data protection is more important than ever. Huawei's OneStorage solution gives operators the efficiency they need to meet these requirements through on-demand resource provisioning, intelligent data management, and multi-cloud convergence. It is currently Huawei's best offering for operators who want to keep their data infrastructure up-to-date and explore new businesses.
By the end of 2021, HUAWEI CLOUD and its partners had built 61 availability zones in 27 areas to serve more than 170 countries and regions. It has also started working with more than 120 operators in the cloud service market to help enterprise customers go digital. It currently offers more than 50 scenario-specific cloud services for nine vertical markets, such as manufacturing, retail, and healthcare, to go digital. These intelligent and efficient data storage services offerings are currently used by 300 operators worldwide and the OceanStor Dorado solution has been named a Leader in Gartner's Magic Quadrant for six years in a row.
Reliable, efficient, and intelligent IT infrastructure is critical for operators to go digital. Huawei wants to continue working with operators to roll out IT infrastructure, help industry go digital, and achieve new growth together.
MWC22 Barcelona will run from February 28 to March 3 in Barcelona, Spain. Huawei will showcase its products and solutions at stand 1H50 in Fira Gran Via Hall 1. Together with global operators, industry professionals, and opinion leaders, we will dive into topics such as industry trends, GUIDE to the Future, and green development to envision the future of digital networks. For more information, please visit: https://carrier.huawei.com/en/events/mwc2022 .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005736/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant Group Unveils China’s First Multimodal AI Assistant with Code-Driven Outputs18.11.2025 09:05:00 CET | Press release
Ant Group today launched LingGuang, a next-generation multimodal AI assistant and the first of its kind in China that interacts with users through code-driven outputs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117438567/en/ Equipped with the capability to understand and produce language, image, voice and data, LingGuang delivers precise, structured responses to complex queries through 3D models, audio clips, charts, animations, interactive maps, and even immediately generated applications, in addition to traditional text-based conversation. Designed around three key features, LingGuang aims to make complex knowledge simpler and more intuitive, transforming how users access information and interact with AI tools. Fast Research: LingGuang responds to user questions or keywords with dynamic, multimodal content, making research on any topic clearer and more engaging. Its 3D digital modeling capability transcends traditio
SkySparc Appoints Oliver Bussmann as Chairman of the Board18.11.2025 09:00:00 CET | Press release
Appointment of industry veteran follows majority growth investment from Bregal Milestone SkySparc, a trusted global provider of digital transformation solutions for treasury and finance organizations, today announced the appointment of Oliver Bussmann as Chairman of the Board, following the closing of a majority growth investment from Bregal Milestone, a leading European software private equity firm. As former Global CIO at UBS and SAP, Bussmann has a proven track record of scaling B2B software and services across the Office of the CFO, Financial Services, RegTech, and WealthTech. Throughout his career, he has guided organizations through complex SaaS transitions, strategic M&A, and go-to-market acceleration – delivering multiple successful exits and sustained enterprise growth. Bussmann will help steer SkySparc’s technology and value-creation agenda, as Chairman, leveraging his network across financial services and technology to accelerate innovation, expand AI adoption, and drive lon
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab18.11.2025 08:23:00 CET | Press release
Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20%1,3Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency3 Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg vials, the formulation is designed to streamline inf
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 08:00:00 CET | Press release
After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support for Japanese research to the new IDEAL Japan initiativeThe “Innovation Debiopharm Academia Life Science” (IDEAL) program is designed to financially and scientifically support academic research with the goal of accelerating the translation of innovation into novel therapies for patientsThe first IDEAL Japan agreement was signed with the National Cancer Center Japan Research Institute Laboratory of Genome Stability Maintenance to advance research in early-stage colon cancer Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approa
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 07:00:00 CET | Press release
MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current launches, and support further product alliances and acquisitions. In just 3 years, Avanzanite has entered 3 strategic alliances and actively launched 3 rare disease medicines. Avanzanite’s Q3 2025 revenue tripled year-on-year and climbed over 20% quarter-on-quarter. Avanzanite is a unique, fully integrated partner for biotech and pharma innovators seeking to market and distribute their rare disease medicines in Europe. A new pan-European standard is being set for orphan medicine launches and patient access, with no one left behind. Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
